These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28723764)

  • 1. Increased nuchal translucency in fetuses with a normal karyotype-diagnosis and management: An observational study.
    Socolov D; Socolov R; Gorduza VE; Butureanu T; Stanculescu R; Carauleanu A; Pavaleanu I
    Medicine (Baltimore); 2017 Jul; 96(29):e7521. PubMed ID: 28723764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of cytogenetic examinations in fetuses with increased nuchal translucency].
    Kornacki J; Ziółkowska K; Goździewicz T; Skrzypczak J
    Ginekol Pol; 2012 Mar; 83(3):189-93. PubMed ID: 22568194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
    Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
    J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased nuchal translucency with normal karyotype].
    Senat MV; Frydman R
    Gynecol Obstet Fertil; 2007 Jun; 35(6):507-15. PubMed ID: 17521948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early amniocentesis and fetal nuchal translucency in women requesting karyotyping for advanced maternal age.
    Salvesen DR; Goble O
    Prenat Diagn; 1995 Oct; 15(10):971-4. PubMed ID: 8587866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency in euploid fetuses--what should we be telling the parents?
    Bilardo CM; Timmerman E; Pajkrt E; van Maarle M
    Prenat Diagn; 2010 Feb; 30(2):93-102. PubMed ID: 20077440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
    Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetal nuchal translucency measurements in women aged 35 and older. Results from 1.1. 99-31.12.00.].
    Harðardóttir H
    Laeknabladid; 2001 May; 87(5):455-7. PubMed ID: 17018986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
    Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
    Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities.
    Haak MC; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):246-52. PubMed ID: 15719441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.